SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model

INTRODUCTION: This Phase 2 clinical trial assessed the efficacy and safety of the novel antioxidative, renewable compound SkQ1 for topical treatment of dry eye signs and symptoms. METHODS: In a single-center, randomized, double-masked, placebo-controlled, 29-day study, 91 subjects with mild to moder...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrov, Anton, Perekhvatova, Natalia, Skulachev, Maxim, Stein, Linda, Ousler, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735228/
https://www.ncbi.nlm.nih.gov/pubmed/26733410
http://dx.doi.org/10.1007/s12325-015-0274-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735228/
https://www.ncbi.nlm.nih.gov/pubmed/26733410
http://dx.doi.org/10.1007/s12325-015-0274-5

Ejemplares similares